Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Temozolomide Treatment Induces HMGB1 to Promote the Formation of Glioma Stem Cells via the TLR2/NEAT1/Wnt Pathway in Glioblastoma
Gao X, Jian Zang, Min Zheng, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Long Non-Coding RNAs in Diagnosis, Treatment, Prognosis, and Progression of Glioma: A State-of-the-Art Review
Sara Momtazmanesh, Nima Rezaei
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 44
Alterations in Molecular Profiles Affecting Glioblastoma Resistance to Radiochemotherapy: Where Does the Good Go?
Juliana Brandstetter Vilar, Markus Christmann, Maja Tomičić
Cancers (2022) Vol. 14, Iss. 10, pp. 2416-2416
Open Access | Times Cited: 23
Hypoxia-induced HMGB1 promotes glioma stem cells self-renewal and tumorigenicity via RAGE
Cuifang Ye, Huan Li, Yachao Li, et al.
iScience (2022) Vol. 25, Iss. 9, pp. 104872-104872
Open Access | Times Cited: 21
Functional Roles of CD133: More than Stemness Associated Factor Regulated by the Microenvironment
Ángela Patricia Moreno-Londoño, Martha Robles‐Flores
Stem Cell Reviews and Reports (2023) Vol. 20, Iss. 1, pp. 25-51
Open Access | Times Cited: 13
Circular RNAs in glioma: Molecular functions and pathological implications
Cheng Tang, Xinyi He, Lintao Jia, et al.
Non-coding RNA Research (2023) Vol. 9, Iss. 1, pp. 105-115
Open Access | Times Cited: 12
Nε-(1-Carboxymethyl)-L-lysine/RAGE Signaling Drives Metastasis and Cancer Stemness through ERK/NFκB axis in Osteosarcoma
Ting-Yu Chang, Kuo‐Cheng Lan, Chia-Hung Wu, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 3, pp. 880-896
Open Access | Times Cited: 3
Long, Noncoding RNA Dysregulation in Glioblastoma
Patrick DeSouza, Xuan Qu, Hao Chen, et al.
Cancers (2021) Vol. 13, Iss. 7, pp. 1604-1604
Open Access | Times Cited: 28
Dialog beyond the Grave: Necrosis in the Tumor Microenvironment and Its Contribution to Tumor Growth
Emilija Zapletal, Tea Vasiljević, Pierre Busson, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5278-5278
Open Access | Times Cited: 10
Involvement of Cyclooxygenase-2 in Establishing an Immunosuppressive Microenvironment in Tumorspheres Derived from TMZ-Resistant Glioblastoma Cell Lines and Primary Cultures
Francesca Lombardi, Francesca Rosaria Augello, Serena Artone, et al.
Cells (2024) Vol. 13, Iss. 3, pp. 258-258
Open Access | Times Cited: 2
Glioma-Stem-Cell-Derived Exosomes Remodeled Glioma-Associated Macrophage via NEAT1/miR-125a/STAT3 Pathway
Tong Pan, Dong-kun Xie, Juan Li, et al.
Cancers (2024) Vol. 16, Iss. 14, pp. 2500-2500
Open Access | Times Cited: 2
Up-Regulation of Cyclooxygenase-2 (COX-2) Expression by Temozolomide (TMZ) in Human Glioblastoma (GBM) Cell Lines
Francesca Lombardi, Francesca Rosaria Augello, Serena Artone, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1545-1545
Open Access | Times Cited: 14
LncRNA NEAT1 Enhances Glioma Progression via Regulating the miR-128-3p/ITGA5 Axis
Jiakai Chen, Handong Wang, Junjun Wang, et al.
Molecular Neurobiology (2021) Vol. 58, Iss. 10, pp. 5163-5177
Open Access | Times Cited: 19
Ivacaftor Inhibits Glioblastoma Stem Cell Maintenance and Tumor Progression
Kun Liu, Jun Pu, Zhi Nie, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 17
Role of RAGE and Its Ligands on Inflammatory Responses to Brain Tumors
Griffith Kyle Otazu, Mojtaba Dayyani, Behnam Badie
Frontiers in Cellular Neuroscience (2021) Vol. 15
Open Access | Times Cited: 14
Long Non-coding RNA KTN1-AS1 Targets miR-505 to Promote Glioblastoma Progression
Kai Guo, Lingling Fang, Mingjian Li, et al.
Behavioural Neurology (2023) Vol. 2023, pp. 1-11
Open Access | Times Cited: 5
Magnolol and Temozolomide exhibit a synergistic anti-glioma activity through MGMT inhibition
Moumita Kundu, Subhayan Das, Suvendu Nandi, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1869, Iss. 7, pp. 166782-166782
Closed Access | Times Cited: 5
Glioblastoma stem cell long non-coding RNAs: therapeutic perspectives and opportunities
Rasmani Hazra, Rinku Debnath, Arati Tuppad
Frontiers in Genetics (2024) Vol. 15
Open Access | Times Cited: 1
The impact of temozolomide and lonafarnib on the stemness marker expression of glioblastoma cells in multicellular spheroids
Pinaki S. Nakod, Raghu Vamsi Kondapaneni, Brandon Edney, et al.
Biotechnology Progress (2022) Vol. 38, Iss. 5
Closed Access | Times Cited: 7
Function of Long Noncoding RNAs in Glioma Progression and Treatment Based on the Wnt/β-Catenin and PI3K/AKT Signaling Pathways
Hanyun Li, Jilan Liu, Xianyun Qin, et al.
Cellular and Molecular Neurobiology (2023) Vol. 43, Iss. 8, pp. 3929-3942
Closed Access | Times Cited: 3
miR-582 negatively regulates pre-B cell proliferation and survival through targeting Hif1α and Rictor
Xinxin Li, Yu-Fei Zhang, Min Zheng, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 2
Open Access | Times Cited: 6
Regulation of temozolomide resistance via lncRNAs: Clinical and biological properties of lncRNAs in gliomas (Review)
Li Sui, Xiaofang Xie, Peng Fu, et al.
International Journal of Oncology (2022) Vol. 61, Iss. 3
Open Access | Times Cited: 6
Modulating glioblastoma chemotherapy response: Evaluating long non-coding RNA effects on DNA damage response, glioma stem cell function, and hypoxic processes
Edith Yuan, Kristie Liu, Justin Lee, et al.
Neuro-Oncology Advances (2022) Vol. 4, Iss. 1
Open Access | Times Cited: 5
Impact of HMGB1 on cancer development and therapeutic insights focused on CNS malignancy
Sucharita Patra, Pritam Roy, Ankita Dey, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 3, pp. 189105-189105
Closed Access
Iloperidone and Temozolomide Synergistically Inhibit Growth, Migration and Enhance Apoptosis in Glioblastoma Cells
Sahar Mubeen, Iffat Raza, Badaruddin Ujjan, et al.
Biomedicines (2024) Vol. 12, Iss. 6, pp. 1134-1134
Open Access
Crocetin Enhances Temozolomide Efficacy in Glioblastoma Therapy Through Multiple Pathway Suppression
Wei-En Tsai, Yen-Tsen Liu, Fu-Hsuan Kuo, et al.
Current Neurovascular Research (2024) Vol. 21, Iss. 3, pp. 320-336
Closed Access
Page 1 - Next Page

Scroll to top